About the Company

Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics markets across emerging economies including India.The company entered into the dermatology market through the launch of its Candid Cream.Glenmarks ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain].The formulations business of the company focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology. India is the largest market in terms of revenue for the organization.

{“success”:1,”data”:{“address”:{“address1″:”B/2, Mahalaxmi Chambers,”,”address2″:”22, Bhulabhai Desai Road,,”,”city”:”Mumbai”,”state”:”Maharashtra”,”pincode”:”400026″,”telephone1″:”022-40189999″,”telephone2″:”022-40189879″,”fax1″:”022-40189986″,”fax2″:””,”email”:”csr@glenmarkpharma.com”,”web”:”http://www.glenmarkpharma.com”},”management”:[{“name”:”Glenn Saldanha”,”designation”:”Chairman & Managing Director”},{“name”:”Cherylann Pinto”,”designation”:”Executive Director – Corporate Affairs”},{“name”:”V S Mani”,”designation”:”Executive Director & Global CFO”},{“name”:”Rajesh V Desai”,”designation”:”Non Executive Director”},{“name”:”Brian W Tempest”,”designation”:”Non Executive Director”}],”registrars”:{“name”:”KFIN Technologies Pvt. Ltd.”,”address1″:”Selenium Tower B, Plot No. 31-32,”,”address2″:”Gachibowli, Financial District, nNanakramguda,Seri”,”address3″:””,”address4″:””,”telephone”:”040-67161500, 67162222, 33211000″,”fax”:”040-23420814, 23001153″,”email”:”einward.ris@karvy.com”,”internet”:”http://www.kfintech.com”,”city”:”Hyderabad”,”state”:”Telangana”,”pincode”:”500032″},”listing”:[{“name”:”BSE 100″,”value”:”No”},{“name”:”BSE 200″,”value”:”No”},{“name”:”SENSEX”,”value”:”No”},{“name”:”CNX MIDCAP 200″,”value”:”Yes”},{“name”:”NIFTY 50″,”value”:”No”},{“name”:”BSE 500″,”value”:”Yes”}],”details”:{“bseId”:”532296″,”nseId”:”GLENMARK”,”series”:”EQ”,”isinid”:”INE935A01035″}}}

• Registered Office

• Registrars

  • Address

    Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

  • City

    Hyderabad 500032

  • State

    Telangana

  • Tel. No.

    040-67161500, 67162222, 33211000

  • Fax No.

    040-23420814, 23001153

  • Email

    einward.ris@karvy.com

  • Internet

    http://www.kfintech.com

• Management

  • Glenn Saldanha

    Chairman & Managing Director

  • Cherylann Pinto

    Executive Director – Corporate Affairs

  • V S Mani

    Executive Director & Global CFO

  • Rajesh V Desai

    Non Executive Director

  • Brian W Tempest

    Non Executive Director

• Included In

  • BSE 100

    No

  • BSE 200

    No

  • SENSEX

    No

  • CNX MIDCAP 200

    Yes

  • NIFTY 50

    No

  • BSE 500

    Yes

• Details

  • BSE:

    532296

  • NSE:

    GLENMARK

  • Series

    EQ

  • ISIN

    INE935A01035

Source